Antibody-drug conjugates remain front and centre of the biopharma world. Following Enhertu’s historic agnostic approval in HER2-positive solid tumours and TIVDAK winning full approval, the field has ...

Improving Prediction & Translation of ADC Toxicities to Drive More Tolerable ADCs Successfully Into & Through Clinical Development Toxicities continue to pose the most significant challenge in the ...

Day One Biopharmaceuticals, now a commercial-stage company after landing FDA approval of its first drug two months ago, is building up its pipeline with a deal that gives it rights to a novel drug ...

Roger is a long-time tech journalist with many site credits including AppleInsider and Android Authority. His specialties include everything from Apple, Android, and Windows devices through to ...

Find out the direct holders, institutional holders and mutual fund holders for ADC Therapeutics SA (ADCT).